Paul Geyer, CEO
Paul Geyer, a successful Medtech Entrepreneur and experienced Board member. Over the past 20 years Paul founded and led two companies through their growth phase, in one case to a successful private exit and in the other case through growth as a public company with numerous acquisitions. Both companies have grown to be anchor medical device companies in the Vancouver area, employing more than 350 people.
In 1991 he founded Mitroflow International Inc., a tissue heart valve company. Paul grew the company from 9 employees to more than 125 employees in 1999. In 1999 Paul sold Mitroflow to Sulzer Medica, for more than $50 mil. Paul's leadership resulted in Mitroflow growing to more than 200 employees, making it one of the largest medical devices companies in the Vancouver area.
In 2001 Paul started Medical Ventures, a new specialty vascular device company where he is currently Chairman of the Board. From its inception to June 2008, Mr. Geyer held the position of CEO at Medical Ventures (now Neovasc) and was responsible for raising over $40 million in Equity financing and growing the company’s product portfolio through internal development and the acquisition of 3 other companies. Neovasc is a public company on the TSX and Nasdaq with a market cap of more than $700mil and continues to grow with operations in both Vancouver and Minneapolis, employing approximately 200 people.
In 2008 Paul began focusing on sharing his expertise to assist other Entrepreneurs to build successful businesses, through his involvement as a mentor or Board member. Mr. Geyer is an active Angel investor in technology and life science companies. In 2010 Paul was awarded the British Columbia Angel Investor of the year, and over the years has invested over $5mil in start-up businesses. He is an active supporter of the local Angel investment community, donating his time to assist local companies and investors through education programs and direct one-on-one mentoring. He is an active alumnus of the Kappa Sigma Fraternity. In 2011 Paul received the BC Life Sciences Leadership Award.
He is also focused on building the local community through his involvement as a Board member of both the Life Sciences and Technology associations, along with a number of non-profit community based organizations. Paul is actively engaged as a Philanthropist as the Chair of the Board of Social Venture Partners Vancouver. He is also involved in a number of other non-profit organizations including Science World Chairs Council, Entrepreneurship at UBC Board member, Project Somos Children’s Village and other local and International organizations.
Paul graduated with a BASc. in Electrical Engineering from the University of British Columbia in 1988 and gained his Professional Engineer status in 1990. He has taken numerous postgraduate courses in Bio-medical Engineering and medical technology and has completed the Canadian Securities Course.
Elisabeth Maurer, President and CTO
Dr. Elisabeth Maurer is the principal inventor of ThromboLUX® and the founder of LightIntegra Technology. Elisabeth has over twenty years of research experience devoting her career to understanding platelet function and the application of dynamic light scattering. She was a scientist with Canadian Blood Services and holds the position of Adjunct Scientist with CBS since 2010. Elisabeth also holds a position as Clinical Associate Professor with the University of British Columbia and is an active member of a number of organizations with a focus on blood transfusion such as AABB, CSTM, ISTH and the UBC CBR. She received her Ph.D. in physical chemistry from the Karl-Franzens University in Graz, Austria.
Gyasi Bourne, VP Engineering
Gyasi Bourne brings 18 years of medical device development experience to the LIT team. As VP of Engineering at Evasc Medical Systems, he played a key role in developing new intravascular implants to address heart disease and stroke. He is an inventor on several issued and pending patents. He is also a principal at Canister Creative, a Communication Design firm that provides creative services to the Life Sciences industry. Gyasi received his BASc. in mechanical engineering from the University of British Columbia, and has spent his entire engineering career bringing new medical devices to market.